Terms: = Leukemia AND CLIP1, ENSG00000130779, 6249, P30622, RSN, MGC131604, CYLN1, CLIP170, CLIP-170, CLIP AND Treatment
6 results:
1. Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer.
Saigí M; Carcereny E; Morán T; Cucurull M; Domènech M; Hernandez A; Martinez-Cardús A; Pros E; Sanchez-Cespedes M
Cancer Treat Rev; 2022 Sep; 109():102430. PubMed ID: 35777135
[TBL] [Abstract] [Full Text] [Related]
2.
Kuželová K; Brodská B; Marková J; Petráčková M; Schetelig J; Ransdorfová Š; Gašová Z; Šálek C
Oncoimmunology; 2022; 11(1):2073050. PubMed ID: 35558161
[TBL] [Abstract] [Full Text] [Related]
3. Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses.
van Luijn MM; Chamuleau ME; Thompson JA; Ostrand-Rosenberg S; Westers TM; Souwer Y; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Haematologica; 2010 Mar; 95(3):485-93. PubMed ID: 19903675
[TBL] [Abstract] [Full Text] [Related]
4. Severe chemotherapy-induced parosmia.
Müller A; Landis BN; Platzbecker U; Holthoff V; Frasnelli J; Hummel T
Am J Rhinol; 2006; 20(4):485-6. PubMed ID: 16955785
[TBL] [Abstract] [Full Text] [Related]
5. [Expression of p16INK4a, p15INK4b, p21WAF1/clip1 cell cycle inhibitors on blastic cells in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) ].
Kapelko-Słowik K; Wołowiec D; Sedek K; Jaźwiec B; Urbaniak-Kujda D; Kuliczkowski K
Pol Arch Med Wewn; 2002 Sep; 108(3):849-53. PubMed ID: 12600181
[TBL] [Abstract] [Full Text] [Related]
6. Divergent regulation of cell surface protease expression in HL-60 cells differentiated into macrophages with granulocyte macrophage colony stimulating factor or neutrophils with retinoic acid.
Laouar A; Wietzerbin J; Bauvois B
Int Immunol; 1993 Aug; 5(8):965-73. PubMed ID: 8398990
[TBL] [Abstract] [Full Text] [Related]
